Clinical analysis of pulmonary infection in hemodialysis patients
- PMID: 24926372
- PMCID: PMC4043622
- DOI: 10.3892/etm.2014.1646
Clinical analysis of pulmonary infection in hemodialysis patients
Abstract
The present study aimed to investigate the pathogen distribution and drug resistance of lung infections in hemodialysis to guide clinical empirical pharmacy. The clinical data of 116 hemodialysis patients with pulmonary infection were analyzed. The majority of the 82 pathogens isolated from the sputa of patients were Gram-negative bacteria (accounting for 71.95%). The results of the drug sensitivity test suggested that Gram-negative bacilli had low resistance rates to piperacillin and tazobactam, imipenem and amikacin, while Gram-positive cocci had a low resistance rate to vancomycin. All resistance rates of the pathogens to other common antimicrobials were >50%. The pathogens resulting in lung infections in hemodialysis patients were mainly Gram-negative bacteria and were significantly resistant to various antibacterials. Results of the this study demonstrate that pathological examination should be performed as early as possible and effective antimicrobial agents should be chosen according to drug sensitivity test results.
Keywords: drug sensitivity test; hemodialysis; pulmonary infection; sputum culture.
Similar articles
-
[Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].Zhonghua Shao Shang Za Zhi. 2016 Sep 20;32(9):529-35. doi: 10.3760/cma.j.issn.1009-2587.2016.09.004. Zhonghua Shao Shang Za Zhi. 2016. PMID: 27647068 Chinese.
-
[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):385-90. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12820914 Chinese.
-
[Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016 Dec 28;41(12):1328-1333. doi: 10.11817/j.issn.1672-7347.2016.12.013. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 28070047 Chinese.
-
Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.Saudi Med J. 2004 Apr;25(4):478-83. Saudi Med J. 2004. PMID: 15083220
-
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.Pharmacoeconomics. 2001;19(11):1135-75. doi: 10.2165/00019053-200119110-00006. Pharmacoeconomics. 2001. PMID: 11735679 Review.
Cited by
-
Comparison of qSOFA Score, SIRS Criteria, and SOFA Score as predictors of mortality in patients with sepsis.Ghana Med J. 2022 Sep;56(3):191-197. doi: 10.4314/gmj.v56i3.9. Ghana Med J. 2022. PMID: 37448998 Free PMC article.
-
Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications.Ren Fail. 2023;45(2):2259996. doi: 10.1080/0886022X.2023.2259996. Epub 2023 Oct 4. Ren Fail. 2023. PMID: 37791567 Free PMC article. Review.
-
The clinical significance of neutrophil-lymphocyte ratio in patients treated with hemodialysis complicated with lung infection.Medicine (Baltimore). 2021 Jul 23;100(29):e26591. doi: 10.1097/MD.0000000000026591. Medicine (Baltimore). 2021. PMID: 34398014 Free PMC article.
-
Analysis of the correlation between serum resistin and the variability of erythropoietin responsiveness in patients with chronic kidney disease.Exp Ther Med. 2015 Nov;10(5):1925-1930. doi: 10.3892/etm.2015.2772. Epub 2015 Sep 23. Exp Ther Med. 2015. PMID: 26640574 Free PMC article.
References
-
- Miyamoto T, Carrero JJ, Stenvinkel P. Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:662–668. - PubMed
-
- O’Seaghdha CM, Foley RN. Septicemia, access, cardiovascular disease, and death in dialysis patients. Perit Dial Int. 2005;25:534–540. - PubMed
-
- Hakim RM, Himmerlfarb J. Hemodialysis access failure: a call to action. Kidney Int. 1998;54:1029–1040. - PubMed
-
- National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–S266. - PubMed
-
- Soni R, Horowitz B, Unruh M. Immunization in end-stage renal disease: opportunity to improve outcomes. Semin Dial. 2013;26:416–426. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources